In this touchENDOCRINOLOGY interview, Dr Christian Hansen (Steno Diabetes Center Copenhagen, Birkerød, Denmark) discusses the unmet needs that remain in the diagnosis and treatment of cardiac autonomic neuropathy.
The abstract entitled: ‘Cardiac Autonomic Neuropathy Sensors for Diabetes‘ was presented at the 22nd Annual Diabetes Technology Meeting, 03-05 Nov, 2022.
- What unmet needs remain and what advances can we expect in the coming years? (0:19)
Disclosures: Christian Hansen has nothing to disclose in relation to this video interview.
Support: Interview supported by Touch Medical Media. Interview conducted by Shanice Allen.
Recorded as a highlight of DTM 2022
Share this Video
Related Videos In Diabetes
José García-Tirado, DTM 2022: RocketAP in Practice: Results from Pilot and Feasibility Trials
In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) gives an overview of RocketAP and discusses how the RocketAP compares to the USS-Virginia system and also what the next steps in the clinical development of the Rocket AP will be. The abstract entitled: ‘RocketAP in Practice: Results from Pilot and Feasibility […]
José García-Tirado, DTM 2022: Challenges in the development of artificial pancreas systems
An artificial pancreas is a system made of three parts that work together to mimic how a healthy pancreas controls blood glucose in the body. In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) discusses the major challenges in the development of artificial pancreas systems. The abstract entitled: ‘RocketAP in Practice: Results from Pilot […]
Carol Levy, DTM 2022: The use of Control-IQ technology in prior MDI and basal-only insulin users with type 2 diabetes
In this touchENDOCRINOLOGY interview, Prof. Carol Levy (Icahn School of Medicine at Mount Sinai, New York City, NY, USA) discusses her study which evaluated adults with type 2 diabetes using the t:slim X2 insulin pump with Control-IQ technology to show that Control-IQ technology could offer considerable benefit to individuals with type 2 diabetes. The abstract […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!